vs

Side-by-side financial comparison of BranchOut Food Inc. (BOF) and CRYO CELL INTERNATIONAL INC (CCEL). Click either name above to swap in a different company.

CRYO CELL INTERNATIONAL INC is the larger business by last-quarter revenue ($7.8M vs $4.0M, roughly 2.0× BranchOut Food Inc.). CRYO CELL INTERNATIONAL INC runs the higher net margin — -48.7% vs -50.6%, a 1.9% gap on every dollar of revenue. On growth, BranchOut Food Inc. posted the faster year-over-year revenue change (181.9% vs -2.3%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $-2.1M). Over the past eight quarters, BranchOut Food Inc.'s revenue compounded faster (65.4% CAGR vs -0.1%).

Food Lion is an American regional supermarket chain headquartered in Salisbury, North Carolina, that operates over 1,000 supermarkets in 10 states: Delaware, Georgia, Kentucky, Maryland, North Carolina, South Carolina, Pennsylvania, Tennessee, Virginia, and West Virginia. The chain employs over 82,000 people. It was founded in 1957 as Food Town, a single grocery store in Salisbury. It later expanded to many locations across North Carolina. It was independently operated until it was acquired b...

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

BOF vs CCEL — Head-to-Head

Bigger by revenue
CCEL
CCEL
2.0× larger
CCEL
$7.8M
$4.0M
BOF
Growing faster (revenue YoY)
BOF
BOF
+184.1% gap
BOF
181.9%
-2.3%
CCEL
Higher net margin
CCEL
CCEL
1.9% more per $
CCEL
-48.7%
-50.6%
BOF
More free cash flow
CCEL
CCEL
$3.3M more FCF
CCEL
$1.2M
$-2.1M
BOF
Faster 2-yr revenue CAGR
BOF
BOF
Annualised
BOF
65.4%
-0.1%
CCEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BOF
BOF
CCEL
CCEL
Revenue
$4.0M
$7.8M
Net Profit
$-2.0M
$-3.8M
Gross Margin
7.6%
77.9%
Operating Margin
-47.6%
-50.6%
Net Margin
-50.6%
-48.7%
Revenue YoY
181.9%
-2.3%
Net Profit YoY
-36.5%
-105.1%
EPS (diluted)
$-0.15
$-0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BOF
BOF
CCEL
CCEL
Q4 25
$4.0M
$7.8M
Q3 25
$3.2M
$7.8M
Q2 25
$3.3M
$7.9M
Q1 25
$3.2M
$8.0M
Q4 24
$1.4M
$8.0M
Q3 24
$2.2M
$8.1M
Q2 24
$1.4M
$8.0M
Q1 24
$1.5M
$7.9M
Net Profit
BOF
BOF
CCEL
CCEL
Q4 25
$-2.0M
$-3.8M
Q3 25
$-1.6M
$749.4K
Q2 25
$-1.6M
$355.8K
Q1 25
$-918.4K
$282.9K
Q4 24
$-1.5M
$-1.9M
Q3 24
$-1.3M
$1.1M
Q2 24
$-942.6K
$655.8K
Q1 24
$-1.1M
$556.2K
Gross Margin
BOF
BOF
CCEL
CCEL
Q4 25
7.6%
77.9%
Q3 25
17.7%
77.0%
Q2 25
18.4%
76.6%
Q1 25
17.3%
75.1%
Q4 24
0.9%
78.4%
Q3 24
15.4%
73.6%
Q2 24
10.9%
74.8%
Q1 24
19.3%
73.7%
Operating Margin
BOF
BOF
CCEL
CCEL
Q4 25
-47.6%
-50.6%
Q3 25
-44.3%
24.3%
Q2 25
-40.8%
18.8%
Q1 25
-21.4%
13.3%
Q4 24
-80.7%
-1.5%
Q3 24
-41.4%
17.2%
Q2 24
-60.6%
17.3%
Q1 24
-69.9%
10.5%
Net Margin
BOF
BOF
CCEL
CCEL
Q4 25
-50.6%
-48.7%
Q3 25
-48.8%
9.6%
Q2 25
-48.6%
4.5%
Q1 25
-28.8%
3.5%
Q4 24
-104.5%
-23.2%
Q3 24
-58.3%
13.0%
Q2 24
-69.2%
8.2%
Q1 24
-71.6%
7.1%
EPS (diluted)
BOF
BOF
CCEL
CCEL
Q4 25
$-0.15
$-0.46
Q3 25
$-0.14
$0.09
Q2 25
$-0.17
$0.04
Q1 25
$-0.11
$0.03
Q4 24
$-0.16
$-0.23
Q3 24
$-0.19
$0.13
Q2 24
$-0.22
$0.08
Q1 24
$-0.26
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BOF
BOF
CCEL
CCEL
Cash + ST InvestmentsLiquidity on hand
$3.3M
Total DebtLower is stronger
$4.9M
$8.4M
Stockholders' EquityBook value
$5.6M
$-18.6M
Total Assets
$14.5M
$61.7M
Debt / EquityLower = less leverage
0.89×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BOF
BOF
CCEL
CCEL
Q4 25
$3.3M
Q3 25
$3.2M
Q2 25
$4.4M
Q1 25
$3.5M
Q4 24
$3.5M
Q3 24
$2.1M
Q2 24
$1.5M
Q1 24
$979.6K
Total Debt
BOF
BOF
CCEL
CCEL
Q4 25
$4.9M
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
BOF
BOF
CCEL
CCEL
Q4 25
$5.6M
$-18.6M
Q3 25
$5.1M
$-14.8M
Q2 25
$3.5M
$-15.6M
Q1 25
$3.9M
$-14.7M
Q4 24
$2.3M
$-13.2M
Q3 24
$1.5M
$-9.6M
Q2 24
$2.0M
$-10.7M
Q1 24
$1.7M
$-10.3M
Total Assets
BOF
BOF
CCEL
CCEL
Q4 25
$14.5M
$61.7M
Q3 25
$14.7M
$63.2M
Q2 25
$13.2M
$64.4M
Q1 25
$14.1M
$64.4M
Q4 24
$12.9M
$64.7M
Q3 24
$9.6M
$62.9M
Q2 24
$6.7M
$62.6M
Q1 24
$2.7M
$61.7M
Debt / Equity
BOF
BOF
CCEL
CCEL
Q4 25
0.89×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BOF
BOF
CCEL
CCEL
Operating Cash FlowLast quarter
$-1.9M
$1.3M
Free Cash FlowOCF − Capex
$-2.1M
$1.2M
FCF MarginFCF / Revenue
-52.6%
15.5%
Capex IntensityCapex / Revenue
4.3%
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.7M
$5.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BOF
BOF
CCEL
CCEL
Q4 25
$-1.9M
$1.3M
Q3 25
$-1.1M
$2.5M
Q2 25
$-2.0M
$707.0K
Q1 25
$-1.9M
$954.1K
Q4 24
$-1.6M
$2.2M
Q3 24
$-1.9M
$2.4M
Q2 24
$-853.9K
$1.8M
Q1 24
$-503.6K
$-356.9K
Free Cash Flow
BOF
BOF
CCEL
CCEL
Q4 25
$-2.1M
$1.2M
Q3 25
$-1.2M
$2.5M
Q2 25
$-2.1M
$644.6K
Q1 25
$-2.3M
$892.0K
Q4 24
$-2.3M
$2.1M
Q3 24
$-3.4M
$2.3M
Q2 24
$-1.4M
$21.5K
Q1 24
$-553.6K
$-814.6K
FCF Margin
BOF
BOF
CCEL
CCEL
Q4 25
-52.6%
15.5%
Q3 25
-37.4%
31.9%
Q2 25
-64.5%
8.1%
Q1 25
-72.2%
11.2%
Q4 24
-163.6%
26.8%
Q3 24
-157.9%
27.9%
Q2 24
-101.3%
0.3%
Q1 24
-37.7%
-10.4%
Capex Intensity
BOF
BOF
CCEL
CCEL
Q4 25
4.3%
0.9%
Q3 25
2.6%
0.5%
Q2 25
3.4%
0.8%
Q1 25
11.8%
0.8%
Q4 24
51.1%
0.1%
Q3 24
70.8%
2.3%
Q2 24
38.6%
21.8%
Q1 24
3.4%
5.8%
Cash Conversion
BOF
BOF
CCEL
CCEL
Q4 25
Q3 25
3.38×
Q2 25
1.99×
Q1 25
3.37×
Q4 24
Q3 24
2.32×
Q2 24
2.70×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons